The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Congress 2024 | Important topics from the MPN Congress 2024: addressing the risk of transformation to acute leukemia
Tariq Mughal, MD, FRCP, FACP, Tufts University School of Medicine, Boston, MA, and Buckingham University Medical School, Buckingham, UK, discusses the complexities of myeloproliferative neoplasms (MPNs) and summarizes some highlights from the 16th International Congress on Myeloproliferative Neoplasms (MPNs), which was recently held in New York City, NY. Dr Mughal provides insight into the transformation of MPNs to acute leukemia in some patients, outlining how this is being addressed in research and clinical practice. This interview took place virtually as part of the 16th International Congress on Myeloproliferative Neoplasms (MPNs) in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
